Alex A. Adjei is Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic. Dr Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites.
He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants.
Dr Adjei has served on a number of National Cancer Institute Committees.
He is currently co-chair of the Thoracic Malignancies Steering Committee.
He is the Editor-in-Chief of the Journal of Thoracic Oncology.
Dr Adjei’s research is focused on experimental therapeutics and clinical drug development.
He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development.
He has authored 260 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.